Endotracheal tubes market seen reaching $1.03 billion by 2030

The global endotracheal tubes market is projected to grow from $0.87 billion in 2026 to $1.03 billion by 2030, driven by more respiratory disease, aging populations and broader use in surgery and emergency care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Endotracheal tubes are a core tool in respiratory care, surgery and emergency airway management. - Growing demand for mechanical ventilation and infection-control-focused devices is shaping procurement and product design across hospitals and ambulatory surgical centers. - The market’s projected 4.5% CAGR through 2030 signals steady expansion rather than a short-term spike.

What happened: - The Business Research Company released its Endotracheal Tubes Market Report 2026 covering market size, trends and a global forecast from 2026 to 2035. - The report estimates the market will rise from $0.83 billion in 2025 to $0.87 billion in 2026. - The report projects the market will reach $1.03 billion by 2030. - North America was the dominant region in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The report links historical growth to more surgical procedures, more respiratory illnesses, expanded critical care units, more emergency admissions and broader use of mechanical ventilation. - The forecast period is supported by an aging population, higher rates of chronic respiratory conditions, stronger demand for emergency airway management and growth in ambulatory surgical centers. - The report also points to greater focus on patient safety and ventilation protocols. - Key forecast trends include higher demand for advanced airway management in critical care settings. - The report expects wider adoption of single-use endotracheal tubes. - It also forecasts more use of cuffed and reinforced tubes to improve surgical safety. - Emergency and trauma care are expected to use these tubes more often. - Infection control and patient protection are becoming more important purchasing factors. - An endotracheal tube is inserted through the mouth or nose into the trachea to keep the airway open and support breathing. - The tube is used during surgeries and emergencies to ensure air reaches the lungs. - The tube can be connected to a ventilator to assist or control breathing. - Rising chronic respiratory disease is a major growth driver. - Pollution, smoking and population aging are contributing to more respiratory disease cases. - In December 2023, the National Center for Biotechnology Information estimated COPD cases would rise by 112 million to 592 million by 2050. - That would equal about 9.5% of the eligible population. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and key technology and future trend analysis. - The company also said the updated package includes new graphics and tables.

Between the lines: - The forecast points to a market supported by durable medical demand rather than a single clinical trend. - Single-use, cuffed and reinforced devices suggest suppliers are competing on safety, infection control and ease of use, not just price. - Asia-Pacific’s expected growth leadership likely reflects expanding hospital capacity and rising respiratory-care needs in faster-growing health systems.

What's next: - The market is expected to keep growing through 2030 as respiratory disease burden and procedural volumes rise. - Product development will likely stay centered on advanced airway management, safety features and infection prevention. - Hospitals and surgical centers may continue shifting toward single-use and reinforced tube formats as standards tighten. - More regional competition is likely as Asia-Pacific accelerates faster than North America.